[Hormonal contraception and postmenopausal estrogen substitution in relation to malignant tumors].
The concept of contraindication of estrogens in patients with endometrial, ovarian and cervical cancer has to be corrected. The German Society of Endocrinology recommend estrogens replacement in cervical, ovarian and vulva carcinoma. Breast and endometrial cancer are relative contraindications. Review of the literature with 104 citations.